NCT04397939View on ClinicalTrials.gov

Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19

CompletedOBSERVATIONAL
Enrollment

4,695

Participants

Timeline

Start Date

May 8, 2020

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions
COVID-19Myocardial Reperfusion InjuryCardiovascular Diseases
Trial Locations (1)

10029

Mount Sinai Hospital, New York

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT04397939 - Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19 | Biotech Hunter | Biotech Hunter